Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (5427)	2/11/1998 6:16:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

<<Viagra will be a 2-4 billion product and the cornerstone of ED management in the future. Expect the announcement of FDA approval within the next month.>> Your credibility is taking a hit with this post Brad; Cornerstone of ED therapy?? Based on what? No substantive reports on efficacy or types of ED treatment have been released. No reports on side effects. FDA approval next month? i don't think so. Viagra wasn't on the last review panel in Jan, and my understanding is that the next review panel isn't til April, which means May approval, if they even get approved. And viagra isn't going to be given a waiver on the review panel. Oh, and btw, PFE was downgraded by one analyst today to a hold <meaning "sell"> based on valuation. Mike